Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Austin, TX, USA, May 08, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Amusement Park Market Size, Trends and Insights By Type (Theme Park, Water Park,...
-
Capital Media Group Inc awarded General Service Administration Multiple Award Schedule (MAS) contract for video, audio, and animation production services.
-
Austin, TX, USA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Tourism Market Size, Trends and Insights By Travel Purpose (Leisure Tourism,...
-
Austin, TX, USA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Tourism Source Market Size, Trends and Insights By Booking Channel (Websites,...
-
Austin, TX, USA, July 06, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Corporate Travel Market Size, Trends and Insights By Service (Transportation,...
-
New York, June 06, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Docks Construction Global Market Report 2023" -...
-
New York, May 23, 2023 (GLOBE NEWSWIRE) -- As per the research report “Global Deck Machinery Market” published by Consegic Business Intelligence, the market was worth USD 2,471.42 Million in 2022...
-
Linthicum, April 19, 2022 (GLOBE NEWSWIRE) -- LINTHICUM, MD, April 18, 2022 – NFM Lending is proud to sponsor ASA RunFest 2022, benefiting Athletes Serving Athletes (ASA). The 5K run & 1K walk...
-
CHESTERBROOK, Pa., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...
-
CHESTERBROOK, Penn., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...